AERIE PHARMACEUTICALS INC. overview

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development, and commercialization of first-in-class ophthalmic therapies, today reports financial results for the third quarter ended September 30, 2022. “Aerie delivered another solid performance in the third quarter and executed well across our three strategic pillars of growth. Our first-in-class glaucoma franchise showed strong continued year-over-year growth, in line with our expectations. We...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Aerie Pharmaceuticals, Inc. (NasdaqGM: AERI) to Alcon Inc. (NYSE: ALC). Under the terms of the proposed transaction, shareholders of Aerie will receive $15.25 in cash for each share of Aerie that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration...

AERIE PHARMACEUTICALS - INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI PR Newswire NEW ORLEANS, Sept. 27, 2022 NEW ORLEANS , Sept. 27, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Aerie Pharmaceuticals, Inc. (NasdaqGM: AERI) to Alcon...

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), a pharmaceutical company focused on the discovery, development, and commercialization of first-in-class ophthalmic therapies, today announced that it will host a Key Opinion Leader (KOL) webinar on Friday, September 23, 2022 from 10:00 a.m. – 11:30 a.m. Eastern Time. The event will feature Dr. Laura Periman, MD, of the Periman Eye Institute, and Dr. John Sheppard, MD, of the Virginia Eye Consultants, who will discuss New Perspectives on Dry Eye...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Aerie Pharmaceuticals, Inc. (NasdaqGM: AERI) to Alcon Inc. (NYSE: ALC). Under the terms of the proposed transaction, shareholders of Aerie will receive $15.25 in cash for each share of Aerie that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration...

Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) to Alcon for $15.25 per share is fair to Aerie shareholders. Halper Sadeh encourages Aerie shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected] . The investigation concerns whether Aerie and its board of directors violated the federal...

SHAREHOLDER ALERT: Weiss Law Investigates Aerie Pharmaceuticals, Inc. PR Newswire NEW YORK, Aug. 23, 2022 NEW YORK , Aug. 23, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Aerie Pharmaceuticals, Inc. ("Aerie" or the "Company") (NASDAQ: AERI), in connection with the proposed acquisition of the Company by Alcon Inc. (NYSE: ALC). Under the terms of the merger agreement, the Company's shareholders will...

Thinking about buying stock in FuboTV, Aerie Pharmaceuticals, Waitr, Tilray, or AMC Entertainment? PR Newswire NEW YORK, Aug. 23, 2022 NEW YORK , Aug. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FUBO, AERI, WTRH, TLRY, and AMC. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. FUBO:...